Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q1 EPS of $0.27, $0.53 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.